Viewing Study NCT01923233


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-25 @ 1:51 AM
Study NCT ID: NCT01923233
Status: WITHDRAWN
Last Update Posted: 2020-01-22
First Post: 2013-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Sponsor: Mirror Biologics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None liver cancer View
None HCC View
None tumor vaccine View
None immunotherapy View